Vanguard Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.2M | Buy |
5,564,259
+1,659,609
| +43% | +$14.7M | ﹤0.01% | 2128 |
|
|
2025
Q1 | $30.6M | Sell |
3,904,650
-48,597
| -1% | -$381K | ﹤0.01% | 2313 |
|
|
2024
Q4 | $41.5M | Buy |
3,953,247
+90,147
| +2% | +$947K | ﹤0.01% | 2245 |
|
|
2024
Q3 | $50.7M | Buy |
3,863,100
+171,737
| +5% | +$2.25M | ﹤0.01% | 2175 |
|
|
2024
Q2 | $51.9M | Buy |
+3,691,363
| New | +$51.9M | ﹤0.01% | 2129 |
|